Skip to main content
Clinical Trials/NCT03831321
NCT03831321
Unknown
Phase 4

The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy

Taha Uçar1 site in 1 country144 target enrollmentDecember 11, 2018

Overview

Phase
Phase 4
Intervention
Diclofenac Sodium
Conditions
Bladder Cancer
Sponsor
Taha Uçar
Enrollment
144
Locations
1
Primary Endpoint
Assesment for operational pain
Last Updated
7 years ago

Overview

Brief Summary

The study was designed as a prospective, randomized double-blind placebo controlled trial. According to power analysis in regards of previous studies in the literature with diclofenac sodium, using a total of 144 patients are needed for Power: 80% and Efficacy: 0.05. diclofenac (20 mg) and placebo drugs to be used in the study will be numbered 1 and 2 individually. Patient randomization was performed using random.org in 144 patients. On the day of cystoscopy, the patient randomized according to inclusion criteria will be given a medication package corresponding to the number given in randomization. It will not be known by the staff and cystoscopy will be performed by the physician who does not know which package is an effective drug.

Parameters:

  1. Visual Pain Score during cystoscopy

  2. Cystoscopy comfort - a questionnaire to be filled by the doctor

    1. Excellent
    2. Very good
    3. Good
    4. Bad
    5. Too bad
  3. Cystoscopy: Is it efficient? Not efficient? - Will be answered by the doctor.

Post-Op:

  1. 1st hour Visual Analog Pain Scale inquiry, dysuria, frequency
  2. 24th Hour dysuria, Frequency,

A total of 144 patients, we plan to arrive at the end of 1 month.

Registry
clinicaltrials.gov
Start Date
December 11, 2018
End Date
May 22, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
Taha Uçar
Responsible Party
Sponsor Investigator
Principal Investigator

Taha Uçar

Resident Doctor

Istanbul Medeniyet University

Eligibility Criteria

Inclusion Criteria

  • Accepted to participate
  • 18-70 years old

Exclusion Criteria

  • Previous peptic ulcer
  • Gastro intestinal bleeding in advance
  • Renal failure
  • Liver failure
  • Patients who underwent cystoscopy for taking or inserting Double J stents 6 - Drug allergies
  • 7- Patients under 18 8- Patients receiving antiaggregant and antiplatelet therapy 9- Patients who do not agree to participate in the study

Arms & Interventions

Diclofenac group

The group who are 50 mg Diclofenac Sodium and lubricant gel administered one hour before cystoscopy and local

Intervention: Diclofenac Sodium

Diclofenac group

The group who are 50 mg Diclofenac Sodium and lubricant gel administered one hour before cystoscopy and local

Intervention: Cystoscopy

Diclofenac group

The group who are 50 mg Diclofenac Sodium and lubricant gel administered one hour before cystoscopy and local

Intervention: Lubricant Gel

Placebo

The group who are not administered 50 mg Diclofenac Sodium before cystoscopy and administered lubricant gel just before local cystoscopy

Intervention: Cystoscopy

Placebo

The group who are not administered 50 mg Diclofenac Sodium before cystoscopy and administered lubricant gel just before local cystoscopy

Intervention: Lubricant Gel

Outcomes

Primary Outcomes

Assesment for operational pain

Time Frame: 1 minute

All the patients will be assessed with Visual pain scale during cystoscopy procedure Scale is a well know pain assesment form which is ranged between 0 to 10 points and higher scores mean worse pain.

Secondary Outcomes

  • Assesment of qualification of cystoscopy(1 minute)
  • Assesment of doctors comfort for the procedure(cystoscopy)(1 minute)

Study Sites (1)

Loading locations...

Similar Trials